Zafgen (NASDAQ: ZFGN) 34% LOWER; announced that it received verbal notice late yesterday from the U.S. Food and Drug Administration ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Wedbush Remains Bullish Following lululemon athletica's (LULU) Warehouse Sale October 20, 2015 8:18 AM Baird Remains Bullish as Market Reacts to Cempra's (CEMP) 2nd Phase 3 Study of Solithromycin October 19, 2015 10:17 AM UBS Reiterates Buy on Schlumberger Ltd. (SLB) Following 3Q Results October 19, 2015 9:27 AM Canaccord Genuity Cuts Price Target on Carrizo Oil & Gas (CRZO) Following 3Q15 Pre-Announcement October 19, 2015 9:19 AM Roth Capital Cuts Price Target on Cempra (CEMP) as Solithromycin Misses High Expectations October 19, 2015 8:53 AM Alibaba (BABA) Announces Acquisition of Remaining YOKU Shares; Wedbush Cuts Price Target to $75 October 19, 2015 8:33 AM Summit Research Reiterates Buy on Alibaba (BABA) Ahead of November 11th Shopping Day October 19, 2015 7:26 AM Cowen Cuts Price Target on Zafgen (ZFGN) as Beloranib is Placed on Hold Following Patient Death October 16, 2015 1:28 PM SOLITAIRE-IV Data Not as Strong as ORAL; Leerink Partners Cuts Price Target on Cempra's (CEMP) to $21 October 16, 2015 1:13 PM MKM Partners Remains Neutral Following Mattel's (MAT) 3Q EPS Miss October 16, 2015 10:40 AM